Wolverine Trading, LLC Humacyte, Inc. Call Options Transaction History

Wolverine Trading, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$5.11 - $9.46 $38,325 - $70,950	7,500 Added 36.76%	27,900 $151,000
Q2 2024 Aug 14, 2024	SELL	$2.87 - $9.1 $27,552 - $87,360	-9,600 Reduced 32.0%	20,400 $97,000
Q1 2024 May 15, 2024	BUY	$2.57 - $4.84 $77,100 - $145,200	30,000 New	30,000 $93,000
Q3 2022 Nov 14, 2022	BUY	$1.22 - $5.14 $18,056 - $76,072	14,800 New	14,800 $50,000
Q1 2022 May 16, 2022	SELL	$4.65 - $7.4 $80,445 - $128,020	-17,300 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.25 - $11.6 $18,125 - $29,000	2,500 Added 16.89%	17,300 $126,000
Q3 2021 Nov 12, 2021	BUY	$9.21 - $16.99 $136,308 - $251,451	14,800 New	14,800 $177,000

150

35.1M

279K

607K

Ticker HUMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,007,000
Market Cap $567M
Description
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.